Lp(a) Apheresis. What We Can Say Today(Symposium 7: LDL and Lp(a) Apheresis)

スポンサーリンク

概要

• 論文の詳細を見る

• There are numerous studies of Lp(a) as a risk factor for atherosclerosis of different localization. A pilot study of Lp(a) apheresis with Lp(a) Lipopak R columns has been carried out in the Cardiology Research Center, Moscow, Russia. During the period of treatment 234 procedures took place. After three years of clinical trials we can say that Lp(a) apheresis is a method of high efficacy and specificity for Lp(a) removal. Our preliminary clinical data give us hope that Lp(a) apheresis may be used as a new therapeutic approach for the management of CHD patients. Additional testing of Lp(a) LipopakR columns have been performed in the UK and Germany.

• 日本アフェレシス学会の論文

著者

• Afanasieva Olga

  Cardiology Research Center

• Sussekov Andrey

  Cardiology Research Center

• Pokrovsky Sergei

  Cardiology Research Center

• Adamova Irina

  Cardiology Research Center

• Kukharchuk Valery

  Cardiology Research Center

関連論文

• Lp(a) Apheresis, Endothelial Dysfunction and Potential for Extracorporeal Correction(Workshop1-12)
• Lp(a) Apheresis. What We Can Say Today(Symposium 7: LDL and Lp(a) Apheresis)

スポンサーリンク